Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06556238 · ClinicalTrials.gov registry record · NA
Metabolism-Informed Care to Aid Alaska Native People to Quit Smoking (QUIT)
A NA study of Smoking Cessation, sponsored by Southcentral Foundation.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06556238: Recruiting NA study of Smoking Cessation, sponsored by Southcentral Foundation.
NCT06556238 is a NA study of Smoking Cessation that is actively recruiting participants, run by Southcentral Foundation. The registered enrollment target is 50 participants, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06556238, a NA study of Smoking Cessation, is actively recruiting participants, sponsored by Southcentral Foundation.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to refine and pilot an intervention using the Nicotine Metabolite Ratio (NMR) to inform the selection of pharmacologic treatment to increase smoking abstinence among Alaska Native and American Indian people. This is a single-arm pilot trial to assess and improve acceptability and feasibility.
Primary Outcome
Proportion of eligible persons who enroll
Conditions Studied
Interventions
- OTHER Nicotine Metabolite Ratio
Study Locations (1)
Alaska
- Anchorage Native Primary Care Center - Anchorage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-11-17 |
| Est. Completion | 2026-06 |
| Phase | NA |
What NCT06556238 shows while recruiting
NCT06556238 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 1 intervention - of which Nicotine Metabolite Ratio is the first listed.
NCT06556238 reports a single indexed study location in Alaska.
Frequently Asked Questions
What is clinical trial NCT06556238 about?
NCT06556238 is a clinical study titled "Metabolism-Informed Care to Aid Alaska Native People to Quit Smoking (QUIT)". The purpose of this study is to refine and pilot an intervention using the Nicotine Metabolite Ratio (NMR) to inform the selection of pharmacologic treatment to increase smoking abstinence among Alaska Native and American Indian people. This is a single-arm pilot trial to assess and improve acceptab...
What is the current status of trial NCT06556238?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-11-17. Estimated completion is 2026-06.
What conditions does trial NCT06556238 study?
This clinical trial studies the following conditions: Smoking Cessation.
What interventions are being tested in trial NCT06556238?
The interventions under investigation include: Nicotine Metabolite Ratio (OTHER).
Who is sponsoring clinical trial NCT06556238?
This trial is sponsored by Southcentral Foundation, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06556238 being conducted?
This trial has 1 study location across Alaska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06556238's enrollment target sits among peer trials
50 145th of 188 higher than 38 of 188 other Smoking Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
RECRUITING · NA
-
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
RECRUITING · NA
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
RECRUITING · NA
-
Urban and Reservation Implementation of All Nations Breath of Life
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI